Ionis Pharmaceuticals moves forward with FDA review of donidalorsen for HAE

Pallavi Madhiraju- November 4, 2024 0

In a significant development for hereditary angioedema (HAE) patients, Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that the U.S. Food and Drug Administration (FDA) has accepted ... Read More

Exicure’s stock explodes 78% overnight – but is the comeback for real?

Pallavi Madhiraju- September 14, 2024 0

Shares of biopharmaceutical company Exicure Inc. skyrocketed by 78% in after-hours trading, closing at $2.84. The surge came after Exicure announced a significant debt-for-equity exchange ... Read More

Convenience store giant Alimentation Couche-Tard to snap up GetGo Café + Market in mega deal

Pallavi Madhiraju- August 20, 2024 0

Alimentation Couche-Tard Inc. has announced a significant move in the convenience retail sector with its acquisition of GetGo Café + Market stores from Giant Eagle ... Read More

How PETRONAS, Enilive, and Euglena’s biorefinery in Malaysia could redefine global energy markets

Pallavi Madhiraju- July 29, 2024 0

Petroliam Nasional Berhad (PETRONAS), Enilive S.p.A, and Euglena Co., Ltd. have reached a major milestone with their final investment decision (FID) to develop a cutting-edge ... Read More